BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37249774)

  • 1. Construction of a novel MPT-driven necrosis-related lncRNAs signature for prognosis prediction in laryngeal squamous cell carcinoma.
    Liu J; Zhang M; Sun Q; Qin X; Gao T; Xu Y; Han S; Zhang Y; Guo Z
    Environ Sci Pollut Res Int; 2023 Jul; 30(31):77210-77225. PubMed ID: 37249774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
    Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
    World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
    Qian L; Ni T; Fei B; Sun H; Ni H
    BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cuproptosis-related LINC02454 as a biomarker for laryngeal squamous cell carcinoma based on a novel risk model and in vitro and in vivo analyses.
    Zhu Q; Zhang R; Lu F; Zhang X; Zhang D; Zhang Y; Chen E; Han F; Zha D
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15185-15206. PubMed ID: 37639011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stemness-related lncRNAs signature as a biologic prognostic model for head and neck squamous cell carcinoma.
    Xu Z; Zhang M; Guo Z; Chen L; Yang X; Li X; Liang Q; Tang Y; Liu J
    Apoptosis; 2023 Jun; 28(5-6):860-880. PubMed ID: 36997733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
    Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
    DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a novel disulfidptosis-related lncRNAs signature for prognosis prediction and anti-tumor immunity in laryngeal squamous cell carcinoma.
    Zhang M; Sun Q; Han Z; Qin X; Gao T; Xu Y; Han S; Zhang Y; Liang Q; Guo Z; Liu J
    Heliyon; 2024 May; 10(10):e30877. PubMed ID: 38774325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA LINC01194 enhances the malignancy of laryngeal squamous cell carcinoma by sponging miR-655 to increase SOX18 expression.
    Liu DM; Yang H; Yuan ZN; Yang XG; Pei R; He HJ
    Biochem Biophys Res Commun; 2020 Aug; 529(2):148-155. PubMed ID: 32703403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel signature derived from metabolism-related genes GPT and SMS to predict prognosis of laryngeal squamous cell carcinoma.
    Shen Y; Huang Q; Zhang Y; Hsueh CY; Zhou L
    Cancer Cell Int; 2022 Jul; 22(1):226. PubMed ID: 35804447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The matrix metalloproteinase gene family: a significant prognostic gene lineage correlated with immune infiltrates in laryngeal squamous cell carcinoma.
    Yang C; Cao H; Yang JW; Liu T; Wang JT; Wang BS
    Neoplasma; 2021 Nov; 68(6):1212-1224. PubMed ID: 34585589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of pyroptosis-related long non-coding RNAs with prognosis and therapy in lung squamous cell carcinoma.
    Zhang Y; Wang Y; Yin X; Huang Y
    Sci Rep; 2022 Jul; 12(1):11206. PubMed ID: 35778526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying prognostic lncRNAs based on a ceRNA regulatory network in laryngeal squamous cell carcinoma.
    Shi Y; Yang D; Qin Y
    BMC Cancer; 2021 Jun; 21(1):705. PubMed ID: 34130645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necrotic related-lncRNAs: Prediction of prognosis and differentiation between cold and hot tumors in head and neck squamous cell carcinoma.
    Shi Y; Zhang Y; Zuo N; Wang L; Sun X; Liang L; Ju M; Di X
    Medicine (Baltimore); 2023 Jun; 102(23):e33994. PubMed ID: 37335630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cuproptosis-related LncRNA signatures as a prognostic model for head and neck squamous cell carcinoma.
    Sun Q; Qin X; Zhao J; Gao T; Xu Y; Chen G; Bai G; Guo Z; Liu J
    Apoptosis; 2023 Feb; 28(1-2):247-262. PubMed ID: 36344660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the Influence of MPT-driven necrosis-linked LncRNAs on immunotherapy outcomes, sensitivity to chemotherapy, and mechanisms of cell death in clear cell renal carcinoma.
    Huang J; Liu M; Chen H; Zhang J; Xie X; Jiang L; Zhang S; Jiang C; Zhang J; Zhang Q; Yang G; Chi H; Tian G
    Front Oncol; 2023; 13():1276715. PubMed ID: 38162499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an immune-related genes signature to predict risk of recurrence for patients with laryngeal squamous cell carcinoma.
    Hong X; Li Y; Lv Q; An J; Liu Y; Wang X; Li R; Hu Y; Liu B
    Int J Immunopathol Pharmacol; 2023; 37():3946320231172075. PubMed ID: 37073715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Roles and mechanisms of m
    Yan BR; Wang P; Li YS; Yang LK; Li QY; Kan X; Wang JT; Sun YN
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1470-1478. PubMed ID: 36707952
    [No Abstract]   [Full Text] [Related]  

  • 20. Aberrant expressed long non-coding RNAs in laryngeal squamous-cell carcinoma.
    Li H; Wang FL; Li W; Fei YH; Wang YT; Zhang JE; Bi HY; Zhang M
    Am J Otolaryngol; 2019; 40(5):615-625. PubMed ID: 31128861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.